|
⚲
|
| Keyboard |
| Doyle Mittie
✚
|
|
|---|---|
| CIK # | 0001918845 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001918845] | |
| 4 | [0001918845] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Doyle Mittie | |
| Avalo Therapeutics Inc | |
| Cullinan Therapeutics Inc | |
| DiCE Molecules Holdings LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2026-03-16 | Option exercise | 19,500 | $12.65 | 246,675 |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 5,992 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2026-03-16 | Option exercise | 19,500 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2026-03-16 | Sell | 25,492 | $16.15 | 411,696 |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2026-03-16 | Option exercise | 5,992 | $8.04 | 48,176 |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2026-02-26 | Grant | 105,000 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2025-12-10 | Tax withheld | 1,013 | $4.10 | 4,153 |
|
Cullinan Therapeutics Inc CGEM
Stock Option (Right to Buy) · derivative
|
2025-08-07 | Grant | 79,456 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2025-01-28 | Grant | 155,000 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2024-07-15 | Grant | 234,000 | $0.00 | |
|
DiCE Molecules Holdings LLC DICE
Stock Option (right to buy) · derivative
|
2023-08-09 | Disposed to issuer | 42,500 | ||
|
DiCE Molecules Holdings LLC DICE
Stock Option (right to buy) · derivative
|
2022-03-31 | Grant | 42,500 | $0.00 |